Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease.

Banks, William A

Banks, William A.

Affiliation

Banks WA; GRECC, Veterans Affairs Medical Center-St. Louis, and Saint Louis University School of Medicine, Division of Geriatrics, Department of Internal Medicine, 915 N. Grand Blvd, St. Louis, MO 63106, USA. bankswa@slu.edu

BMC Neurosci ; 9 Suppl 3: S2, 2008 Dec 10.

Article in En | MEDLINE | ID: mdl-19090999

Subject(s)

Blood-Brain Barrier/metabolism; Central Nervous System Agents/administration & dosage; Drug Delivery Systems/methods; Drug Design; Alzheimer Disease/drug therapy; Alzheimer Disease/metabolism; Animals; Anti-Infective Agents/administration & dosage; Anti-Infective Agents/pharmacokinetics; Anti-Infective Agents/therapeutic use; Central Nervous System Agents/pharmacokinetics; Central Nervous System Agents/therapeutic use; Humans; Neuropeptides/administration & dosage; Neuropeptides/pharmacokinetics; Neuropeptides/therapeutic use; Peptides/administration & dosage; Peptides/pharmacokinetics; Peptides/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Blood-Brain Barrier / Drug Design / Central Nervous System Agents / Drug Delivery Systems Limits: Animals / Humans Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google